• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低 TRIM44 通过抑制 Wnt/β-catenin 信号通路抑制甲状腺乳头状癌细胞的增殖和侵袭。

Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.

机构信息

Department of Thyroid and Breast, Huaihe Hospital, Henan University, Kaifeng 475000, People's Republic of China.

Department of Endocrinology, Huaihe Hospital, Henan University, Kaifeng 475000, People's Republic of China.

出版信息

Biomed Pharmacother. 2017 Dec;96:98-103. doi: 10.1016/j.biopha.2017.09.132. Epub 2017 Sep 29.

DOI:10.1016/j.biopha.2017.09.132
PMID:28965013
Abstract

Tripartite motif 44 (TRIM44), a member of the TRIM family, functions as a critical regulator in several types of malignancy. However, the role of TRIM44 in thyroid cancer has never been revealed. Thus, in this study, to explore its role in PTC, we detected its expression patterns in human papillary thyroid cancer (PTC) tissues and cell lines, and investigated its effects on cell proliferation and invasion. Our results demonstrated that TRIM44 was highly expressed in human PTC tissues and cell lines. In addition, silencing of TRIM44 significantly suppressed the proliferation, migration/invasion, and the epithelial-mesenchymal transition (EMT) process in PTC cells. Furthermore, silencing of TRIM44 dramatically down-regulated the expression of β-catenin, cyclin-D1 and c-Myc in PEC cells, and the activator of the Wnt/β-catenin pathway LiCl rescued the anticancer effect of knockdown TRIM44 expression in PTC cells. In conclusion, this study reported here provided evidence that TRIM44 functions as an oncogene in PTC. Silencing of TRIM44 inhibits the proliferation, migration and invasion of PTC cells in part through suppression of the Wnt/β-catenin signaling pathway. Thus, TRIM44 may be a potential therapeutic target for the treatment of PTC.

摘要

三结构域蛋白 44(TRIM44)是 TRIM 家族的成员,在几种类型的恶性肿瘤中作为关键调节因子发挥作用。然而,TRIM44 在甲状腺癌中的作用从未被揭示。因此,在这项研究中,为了探索其在 PTC 中的作用,我们检测了其在人甲状腺乳头状癌(PTC)组织和细胞系中的表达模式,并研究了其对细胞增殖和侵袭的影响。我们的研究结果表明,TRIM44 在人 PTC 组织和细胞系中高度表达。此外,沉默 TRIM44 显著抑制 PTC 细胞的增殖、迁移/侵袭和上皮-间充质转化(EMT)过程。此外,沉默 TRIM44 可显著下调 PEC 细胞中β-连环蛋白、细胞周期蛋白 D1 和 c-Myc 的表达,Wnt/β-连环蛋白通路的激活剂 LiCl 挽救了敲低 TRIM44 表达对 PTC 细胞的抗癌作用。总之,本研究报道了 TRIM44 作为 PTC 中的癌基因的证据。沉默 TRIM44 可部分通过抑制 Wnt/β-连环蛋白信号通路抑制 PTC 细胞的增殖、迁移和侵袭。因此,TRIM44 可能是治疗 PTC 的潜在治疗靶点。

相似文献

1
Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.敲低 TRIM44 通过抑制 Wnt/β-catenin 信号通路抑制甲状腺乳头状癌细胞的增殖和侵袭。
Biomed Pharmacother. 2017 Dec;96:98-103. doi: 10.1016/j.biopha.2017.09.132. Epub 2017 Sep 29.
2
FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.FOXE1 通过 Wnt/β-catenin 通路支持 Gli2 促进甲状腺乳头状癌的肿瘤发生。
J Cell Physiol. 2019 Aug;234(10):17739-17748. doi: 10.1002/jcp.28399. Epub 2019 Feb 22.
3
LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.长链非编码 RNA SNHG12 通过调控 wnt/β-连环蛋白信号通路促进甲状腺乳头状癌细胞的增殖和转移。
Cancer Biomark. 2018;22(2):217-226. doi: 10.3233/CBM-170777.
4
SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition Wnt/β-Catenin Pathway.SDC4 基因沉默促进人甲状腺乳头状癌细胞凋亡并抑制上皮间质转化 Wnt/β-连环蛋白通路。
Mol Cells. 2018 Sep 30;41(9):853-867. doi: 10.14348/molcells.2018.0103. Epub 2018 Aug 31.
5
LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.长链非编码RNA PTCSC3/微小RNA-574-5p通过Wnt/β-连环蛋白信号通路调控甲状腺乳头状癌的细胞增殖和迁移
J Cell Biochem. 2017 Dec;118(12):4745-4752. doi: 10.1002/jcb.26142. Epub 2017 Jun 22.
6
LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.LGR5与甲状腺乳头状癌的肿瘤侵袭性相关。
Oncotarget. 2015 Oct 27;6(33):34549-60. doi: 10.18632/oncotarget.5330.
7
LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.LINC00958/miR-627信号轴通过TRIM44调控甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Kaohsiung J Med Sci. 2022 May;38(5):415-424. doi: 10.1002/kjm2.12502. Epub 2022 Feb 24.
8
Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.Dickkopf-1通过调控β-连环蛋白/E-钙黏蛋白信号通路在野生型BRAF甲状腺乳头状癌中的治疗潜力
J Clin Endocrinol Metab. 2014 Sep;99(9):E1641-9. doi: 10.1210/jc.2013-4467. Epub 2014 May 21.
9
Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.下调 CSN6 通过降低 Wnt/β-catenin 信号通路抑制甲状腺乳头状癌细胞的进展并增加癌细胞对 FH535 治疗的敏感性。
Cancer Med. 2018 Feb;7(2):285-296. doi: 10.1002/cam4.1272. Epub 2018 Jan 17.
10
Knockdown of SOX9 Inhibits the Proliferation, Invasion, and EMT in Thyroid Cancer Cells.SOX9基因敲低抑制甲状腺癌细胞的增殖、侵袭和上皮-间质转化
Oncol Res. 2017 Jan 26;25(2):167-176. doi: 10.3727/096504016X14732772150307.

引用本文的文献

1
The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic Review.三方基序蛋白在泌尿系统癌症中的作用:一项系统综述
Cancers (Basel). 2025 Jul 16;17(14):2367. doi: 10.3390/cancers17142367.
2
TRIM44 facilitates aggressive behaviors in multiple myeloma through promoting ZEB1 deubiquitination.TRIM44通过促进ZEB1去泛素化促进多发性骨髓瘤的侵袭性。
Discov Oncol. 2025 Feb 27;16(1):248. doi: 10.1007/s12672-025-01933-5.
3
TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer.
TRIM25、TRIM28和TRIM59及其在癌症信号串扰中的蛋白质伙伴:癌症潜在的新型治疗靶点
Curr Issues Mol Biol. 2024 Sep 25;46(10):10745-10761. doi: 10.3390/cimb46100638.
4
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks.甲状腺乳头状癌的高侵袭性:从临床证据到调控细胞网络
Cell Death Discov. 2024 Aug 26;10(1):378. doi: 10.1038/s41420-024-02157-2.
5
Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.甲状腺癌中的泛素修饰酶:机制与功能
Heliyon. 2024 Jul 2;10(13):e34032. doi: 10.1016/j.heliyon.2024.e34032. eCollection 2024 Jul 15.
6
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape.错综复杂的对抗:TRIM 家族蛋白在肿瘤免疫逃逸中的研究进展与应用潜力。
J Adv Res. 2023 Dec;54:147-179. doi: 10.1016/j.jare.2023.01.011. Epub 2023 Feb 2.
7
TRIM21‑a potential biomarker for the prognosis of thyroid cancer.TRIM21——一种甲状腺癌预后的潜在生物标志物。
Exp Ther Med. 2022 Nov 9;24(6):761. doi: 10.3892/etm.2022.11697. eCollection 2022 Dec.
8
The roles and targeting options of TRIM family proteins in tumor.TRIM家族蛋白在肿瘤中的作用及靶向选择
Front Pharmacol. 2022 Sep 30;13:999380. doi: 10.3389/fphar.2022.999380. eCollection 2022.
9
Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.心脏特异性 Trim44 敲除可通过抑制 AKT/mTOR 通路减轻异丙肾上腺素诱导的心脏重构。
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.049444. Epub 2022 Aug 18.
10
Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.胃癌患者 TRIM44 表达的临床意义。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1725-1731. doi: 10.31557/APJCP.2022.23.5.1725.